{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:59:31Z","timestamp":1783573171653,"version":"3.55.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1053\/j.seminoncol.2015.07.002","type":"journal-article","created":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T05:37:42Z","timestamp":1436247462000},"page":"e81-e94","source":"Crossref","is-referenced-by-count":12,"title":["Metastasis to the Cervix Uteri 15 Years After Treatment of Lobular Carcinoma of the Breast"],"prefix":"10.1053","volume":"42","author":[{"given":"Adrienne G.","family":"Waks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Lennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Budhi S.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"dSchapirael Carmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Schapira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Gilman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Overmoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.seminoncol.2015.07.002_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2559.1979.tb03029.x","article-title":"Invasive lobular carcinoma of the breast: incidence and variants","volume":"3","author":"Martinez","year":"1979","journal-title":"Histopathology"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/986517","article-title":"Case report: unusual metastatic patterns of invasive lobular carcinoma of the breast","author":"Sobinsky","year":"2013","journal-title":"Case Rep Oncol Med"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2214\/ajr.175.3.1750795","article-title":"Metastatic lobular carcinoma of the breast: patterns of spread in the chest, abdomen, and pelvis on CT","volume":"175","author":"Winston","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jso.2930480106","article-title":"Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study","volume":"48","author":"Lamovec","year":"1991","journal-title":"J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4048\/jbc.2011.14.3.247","article-title":"Invasive lobular breast cancer presenting an unusual metastatic pattern in the form of peritoneal and rectal metastases: a case report","volume":"14","author":"Saranovic","year":"2011","journal-title":"J Breast Cancer"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/bjc.1984.135","article-title":"A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast","volume":"50","author":"Harris","year":"1984","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1053\/j.seminoncol.2015.07.002_bib7","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/bcr767","article-title":"Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome","volume":"6","author":"Arpino","year":"2004","journal-title":"Breast Cancer Res"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib8","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1200\/JCO.2007.14.9336","article-title":"Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials","volume":"26","author":"Pestalozzi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1309\/YMJ3A83TB39MRUT9","article-title":"Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3,655 invasive breast carcinomas","volume":"123","author":"Lal","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib10","series-title":"Robins basic pathology","author":"Kumar","year":"2007"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/modpathol.2012.197","article-title":"Pleomorphic lobular carcinoma of the breast: is it a prognostically significant pathological subtype independent of histological grade?","volume":"26","author":"Rakha","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2214\/ajr.161.5.8273634","article-title":"Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients","volume":"161","author":"Krecke","year":"1993","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib13","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2214\/ajr.161.5.8273634","article-title":"Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases","volume":"50","author":"Kumar","year":"1982","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1309\/CPUX-KWEH-7B26-YE19","article-title":"Cytokertatin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma","volume":"114","author":"Lehr","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/PAS.0b013e318158d6c5","article-title":"Aberrant expression of E-cadherin in lobular carcinomas of the breast","volume":"32","author":"Da Silva","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","article-title":"Immunohistochemical evaluation of GATA3 expression in tumors and normal tissue: a useful immunomarker for breast and urothelial carcinoma","volume":"138","author":"Liu","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"15","key":"10.1053\/j.seminoncol.2015.07.002_bib17","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/0959-8049(93)90053-I","article-title":"Patterns of metastatic breast cancer in relation to histological type","volume":"29A","author":"Jain","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib18","doi-asserted-by":"crossref","first-page":"e7695","DOI":"10.1371\/journal.pone.0007695","article-title":"Breast cancer in young women: poor survival despite intensive treatment","volume":"4","author":"Fredholm","year":"2009","journal-title":"Plos One"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/91.1.80","article-title":"Dormancy of mammary carcinoma after mastectomy","volume":"91","author":"Karrison","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib20","doi-asserted-by":"crossref","first-page":"e1000279","DOI":"10.1371\/journal.pmed.1000279","article-title":"Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies","volume":"7","author":"Blows","year":"2010","journal-title":"PLoS Mede"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib21","first-page":"183","article-title":"Dormancy in breast cancer","volume":"4","author":"Banys","year":"2012","journal-title":"Breast Cancer"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib22","unstructured":"Cervical cancer incidence, mortality and prevalence worldwide in 2008: Summary. http:\/\/globocan.iarc.fr\/factsheet.asp. Accessed December 29, 2014."},{"key":"10.1053\/j.seminoncol.2015.07.002_bib23","unstructured":"WHO\/ICO Information Center of HPV and Cervical Cancer (HPV Information Center). Human papillomavirus and related cancers in the world. Summary report 2010. http:\/\/www.who.int\/hpvcentre\/en\/. Accessed December 29, 2014."},{"issue":"1","key":"10.1053\/j.seminoncol.2015.07.002_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.22357","article-title":"Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8, 097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies","volume":"120","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa011688","article-title":"Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners","volume":"346","author":"Castellsagu\u00e9","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijgo.2009.02.009","article-title":"Revised FIGO staging for carcinoma of the cervix","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib28","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib29","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2007.09.022","article-title":"Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer","volume":"108","author":"Kim","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib31","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ctrv.2011.06.009","article-title":"Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review","volume":"38","author":"Iqbal","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","volume":"378","author":"Davies","year":"2011","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib33","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1200\/JCO.2009.22.3248","article-title":"Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2","volume":"27","author":"Walker","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib34","unstructured":"www.adjuvantonline.com. Accessed January 16, 2015."},{"issue":"15","key":"10.1053\/j.seminoncol.2015.07.002_bib35","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1158\/1078-0432.CCR-13-0804","article-title":"Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrence","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1053\/j.seminoncol.2015.07.002_bib36","first-page":"637","article-title":"Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast","volume":"114","author":"Borst","year":"1993","journal-title":"Surgery"},{"issue":"5","key":"10.1053\/j.seminoncol.2015.07.002_bib37","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/PAS.0b013e3181d6b8fd","article-title":"Metastatic carcinomas in the cervix mimicking primary cervical adenocarcinoma and adenocarcinoma in situ: report of a series of cases","volume":"34","author":"McCluggage","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1053\/j.seminoncol.2015.07.002_bib38","first-page":"469","article-title":"Solitary metastasis to the uterine cervix from the early gastric cancer: a case report","volume":"21","author":"Yokoyama","year":"2000","journal-title":"Eur J Gynaecol Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2015.07.002_bib39","first-page":"54","article-title":"Adenocarcinoma of the uterine cervix metastatic from primary stomach cancer. Cytologic findings in six cases","volume":"27","author":"Kashimura","year":"1983","journal-title":"Acta Cytol"},{"issue":"3","key":"10.1053\/j.seminoncol.2015.07.002_bib40","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1447-0756.2011.01747.x","article-title":"Adenocarcinoma metastatic to the uterine cervix: a case series","volume":"38","author":"P\u00e9rez-Montiel","year":"2012","journal-title":"J Obstet Gynaecol Res"},{"issue":"12","key":"10.1053\/j.seminoncol.2015.07.002_bib41","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/jjco\/29.12.640","article-title":"Uterine cervix metastasis from rectal carcinoma: a case report and a review of the literature","volume":"29","author":"Nakagami","year":"1999","journal-title":"Jpn J Clin Oncol"},{"issue":"10","key":"10.1053\/j.seminoncol.2015.07.002_bib42","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/1097-0142(19860515)57:10<2002::AID-CNCR2820571021>3.0.CO;2-L","article-title":"Epithelial tumors metastatic to the uterine cervix. A study of 33 cases and review of the literature","volume":"57","author":"Lemoine","year":"1986","journal-title":"Cancer"},{"issue":"9","key":"10.1053\/j.seminoncol.2015.07.002_bib43","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/1097-0142(19840501)53:9<1978::AID-CNCR2820530929>3.0.CO;2-1","article-title":"Metastases to the female genital tract. Analysis of 325 cases","volume":"53","author":"Mazur","year":"1984","journal-title":"Cancer"},{"issue":"1","key":"10.1053\/j.seminoncol.2015.07.002_bib44","first-page":"30","article-title":"Breast cancer metastasising to the uterine cervix","volume":"68","author":"Bryson","year":"1999","journal-title":"Ulster Med J"},{"issue":"4","key":"10.1053\/j.seminoncol.2015.07.002_bib45","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S1028-4559(09)60261-8","article-title":"Recurrent breast cancer presents as a single solid ovarian mass and ascites","volume":"45","author":"Chen","year":"2006","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib46","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1093\/annonc\/mdu456","article-title":"Everolims plus exemestane for hormone-receptor positive, human epidermal growth factor receptor-2 negative advanced breast cancer: overall survival results from BOLERO-2","volume":"25","author":"Piccart","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib47","article-title":"The cyclin-dependent kinase 4\/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1\/TRIO-18): a randomised phase 2 study","author":"Finn","year":"2014","journal-title":"Lancet Oncol"},{"issue":"9869","key":"10.1053\/j.seminoncol.2015.07.002_bib48","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor positive breast cancer: ATLAS, a randomized trial","volume":"381","author":"Davies","year":"2013","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib49","unstructured":"Francis PA, Regan MM, Fleming GF. Adjuvant ovarian suppression in premenopausal breast cancer. N Engl J Med. 2014 Dec."},{"issue":"2","key":"10.1053\/j.seminoncol.2015.07.002_bib50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/annonc\/mds330","article-title":"Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo controlled NCIC CTG MA17 trial of extended adjuvant letrozole","volume":"24","author":"Goss","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib51","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S1470-2045(13)70322-X","volume":"4","author":"Johnston","year":"2013","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib52","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1128\/JVI.63.10.4417-4421.1989","article-title":"The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes","volume":"63","author":"Munger","year":"1989","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib53","series-title":"Abeloff\u2019s clinical oncology","author":"Niederhuber","year":"2014"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003370.pub3","article-title":"Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women","author":"Gibson","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib55","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1200\/JCO.2000.18.22.3758","article-title":"Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in post-menopausal women: results of a North American multicenter randomized trial. Arimidex Study Group","volume":"18","author":"Nabholtz","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib56","unstructured":"National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. Genetic\/familial high-risk assessment: breast and ovarian, Version 1.2014."},{"key":"10.1053\/j.seminoncol.2015.07.002_bib57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antonis","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib58","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/jmg.2007.051268","article-title":"Germline E-cadherin mutations in familial lobular breast cancer","volume":"44","author":"Masciari","year":"2007","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib59","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10549-006-9231-y","article-title":"Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer","volume":"100","author":"Anderson","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/A:1022166517963","article-title":"Estrogen receptors and distinct patterns of breast cancer relapse","volume":"78","author":"Hess","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib61","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00404-007-0535-x","article-title":"Breast cancer, ovarian gonadoblastoma and cervical cancer in a patient with Peutz-Jeghers Syndrome","volume":"278","author":"Kilic-Okman","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib62","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.aogh.2014.09.013","article-title":"Infection and cancer: global distribution and burden of diseases","volume":"80","author":"Oh","year":"2014","journal-title":"Ann Glob Health"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib63","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/annonc\/mdt384","article-title":"PARP inhibitors for BRCA1\/2 mutation-associated and BRCA-like malignancies","volume":"25","author":"Lee","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib64","unstructured":"Tutt A, Ellis P, Kilburn L, et al. TNT: a randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative or BRCA1\/2 breast cancer. San Antonio Breast Cancer Symposium. 2014;abstract S3-01."},{"key":"10.1053\/j.seminoncol.2015.07.002_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002747","article-title":"Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer","author":"Wilcken","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib66","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Breast cancer. Version 3.2014:http:\/\/www.nccn.org, 2014."},{"key":"10.1053\/j.seminoncol.2015.07.002_bib67","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/jnci\/djj357","article-title":"Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis","volume":"98","author":"Mauri","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib68","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1056\/NEJMoa1201622","article-title":"Combination anastrozole and fulvestrant in metastatic breast cancer","volume":"367","author":"Mehta","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib69","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1200\/JCO.2011.38.1095","article-title":"FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer","volume":"30","author":"Bergh","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib70","doi-asserted-by":"crossref","unstructured":"Robertson JFR, Llombart-Cussac A, Feltl D, et al. Fulvestrant 500 mg versus anastrozole as first-line treatment for advanced breast cancer: overall survival from the phase II \u201cfirst\u201d study. San Antonio Breast Cancer Symposium. 2014; abstract S6-04.","DOI":"10.1158\/1538-7445.SABCS14-S6-04"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib71","unstructured":"A Global Study to compare the Effects of Fulvestrant and Arimidex in a Subset of Patients with Breast Cancer (FALCON). http:\/\/www.clincaltrials.gov, Identifier: NCT01602380. Accessed January 30, 2015."},{"key":"10.1053\/j.seminoncol.2015.07.002_bib72","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1109653","article-title":"Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib73","unstructured":"Palbociclib (PD-0332991) combined with Fulvestrant in Hormone-Receptor-Positive HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3). http:\/\/www.clincaltrials.gov, Identifier: NCT01942135. Accessed January 30, 2015."},{"key":"10.1053\/j.seminoncol.2015.07.002_bib74","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/jnci\/djp235","article-title":"International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy","volume":"101","author":"Cardoso","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib75","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0002-9440(10)65689-1","article-title":"Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions","volume":"153","author":"Sano","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib76","first-page":"494","article-title":"p63 expression profiles in human normal and tumor tissues","volume":"8","author":"Di Como","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib77","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1309\/21TW-2NDG-JRK4-PFJX","article-title":"Value of p63 and cytokeratin 5\/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas","volume":"116","author":"Kaufmann","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib78","first-page":"9","article-title":"Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis","volume":"42","author":"Avril","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib79","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1053\/j.seminoncol.2014.12.020","article-title":"Synchronous primary carcinoma of breast and ovary versus ovarian metastases","volume":"42","author":"Yadav","year":"2015","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib80","first-page":"347","article-title":"Metastatic breast cancer to the uterine cervix mimicking a giant cervical leiomyoma","volume":"74","author":"Horikawa","year":"2012","journal-title":"Nagoya J Med Sci"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib81","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3109\/07357909909032855","article-title":"Breast cancer metastatic to the uterine cervix: analysis of a rare event","volume":"17","author":"Hepp","year":"1999","journal-title":"Cancer Invest"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib82","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2303.2011.00945.x","article-title":"Cytomorphological features of extra-genital metastases in SurePath cervical liquid-based cytology: a series of eight cases","volume":"24","author":"Gupta","year":"2013","journal-title":"Cytopathology"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib83","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1158\/1078-0432.CCR-13-0838","article-title":"Metastasis dormancy in estrogen receptor-positive breast cancer","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2015.07.002_bib84","unstructured":"Gray RG, Rea D, Handley K, et al. aTTom: long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer. 2013 ASCO Annual Meeting Plenary Session, Plenary Session Including FDA Commissioner Address, Public Service Award, and Science of Oncology Award and Lecture. J Clin Oncol. 2013;31 (suppl): abstr 5."}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775415001153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775415001153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T18:39:28Z","timestamp":1599244768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775415001153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0093775415001153"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2015.07.002","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}